|
|
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot Applicable 多库苯佐灌肠剂治疗慢性便秘伴排便时肛门疼痛的多中心、随机、双盲、安慰剂平行对照的有效性和安全性的试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of docubenzone enema in the treatment of chronic constipation with anal pain during defecation
评价多库苯佐灌肠剂用于治疗慢性便秘伴排便时肛门疼痛患者的有效性和安全性,为其在国内进行药品注册提供科学可靠的临床数据。
[Translation] To evaluate the efficacy and safety of docubenzone enema in the treatment of patients with chronic constipation and anal pain during defecation, and to provide scientific and reliable clinical data for its drug registration in China.
/ Active, not recruitingNot Applicable 多库酯钠灌肠剂改善便秘症状的多中心、随机、双盲双模拟、阳性药物平行对照临床试验
[Translation] A multicenter, randomized, double-blind, double-dummy, positive drug parallel controlled clinical trial of docusate sodium enema in improving constipation symptoms
[Translation] To evaluate the efficacy and safety of docusate sodium enema in improving constipation symptoms
100 Clinical Results associated with Beijing Beiliyuan Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Beiliyuan Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Beiliyuan Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Beiliyuan Pharmaceutical Technology Co., Ltd.